|
|
News
June, 15, 2010
|
|
2cureX selected as one
of the top 30 high-growth technology companies in the Nordic region. |
| |
|
|
| June, 8, 2010 |
 |
2cureX announces issuance of final patent
completing the protection of the ChemoCellomics® technology.
|
| |
|
|
| October 21, 2009 |
|
2cureX announces issuance of patent
on its
ChemoCellomics® technology. |
| |
|
|
| March 1, 2009 |
|
2cureX’s ChemoCellomics®
technology is supported by EU. |
| |
|
|
| October 31, 2008 |
|
DELTA and 2cureX establish
strategic partnership and expand its board of directors. |
| |
|
|
| November 1, 2007 |
|
2cureX’s CEO
Ole Thastrup appointed Adjunct Professor at University of Copenhagen |
| |
|
|
| April
25, 2007 |
|
2cureX participated in
the Danish Galathea 3, around the globe, marine expedition. |
| |
|
|
| December
11, 2006 |
|
2cureX
- a new Drug Discovery Company. |
|
